Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2198]
News [6144]
Articles [126]
Editorials [31]
Conferences [201]
elearning [22]
Clinical updates for metastatic hormone sensitive prostate cancer at ASCO 2019
Prof Rob Jones, Prof Nick James, Prof Ian Davis, Prof Axel Merseburger
Clinical updates for metastatic hormone sensitive prostate cancer at ASCO 2019 ( Prof Rob Jones, Prof Nick James, Prof Ian Davis, Prof Axel Merseburger )
3 Jun 2019
Metastatic bladder cancer: Current practice and latest data from ASCO 2019
Dr Andrea Necchi, Dr Petros Grivas, Prof Arlene Siefker-Radtke, Prof Rob Jones
Metastatic bladder cancer: Current practice and latest data from ASCO 2019 ( Dr Andrea Necchi, Dr Petros Grivas, Prof Arlene Siefker-Radtke, Prof Rob Jones )
3 Jun 2019
Highlights from ASCO 2019
Asst. Prof Bishal Gyawali and Monique Biryiana
Highlights from ASCO 2019 ( Asst. Prof Bishal Gyawali and Monique Biryiana )
3 Jun 2019
Understanding eligibility criteria for clinical trials to increase study size
Dr R. Donald Harvey - Winship Cancer Institute of Emory University, Druid Hills...
Understanding eligibility criteria for clinical trials to increase study size ( Dr R. Donald Harvey - Winship Cancer Institute of Emory University, Druid Hills, Georgia )
3 Jun 2019
Novel therapies in the treatment of bladder cancer
Dr Petros Grivas and Dr Andrea Necchi
Novel therapies in the treatment of bladder cancer ( Dr Petros Grivas and Dr Andrea Necchi )
3 Jun 2019
PARP inhibitors are a promising alternative to chemotherapy for patients with...
Dr Sara A. Hurvitz - UCLA Jonsson Comprehensive Cancer Center, Los Angeles, USA
PARP inhibitors are a promising alternative to chemotherapy for patients with metastatic BRCA1 and BRCA2 breast cancer ( Dr Sara A. Hurvitz - UCLA Jonsson Comprehensive Cancer Center, Los Angeles, USA )
1 Jun 2019
Latest in ovarian cancer treatment
Dr Susana Banerjee - The Royal Marsden NHS Foundation Trust, London, UK
Latest in ovarian cancer treatment ( Dr Susana Banerjee - The Royal Marsden NHS Foundation Trust, London, UK )
24 May 2019
Artificial intelligence and treatment decisions
Dr Pratik Shah - Massachusetts Institute of Technology, Cambridge, USA
Artificial intelligence and treatment decisions ( Dr Pratik Shah - Massachusetts Institute of Technology, Cambridge, USA )
24 May 2019
Metabolic vulnerability in NOTCH-driven T cell acute lymphoblastic leukaemia
Dr Etienne De Braekeleer - Wellcome Sanger Institute, Cambridge, UK
Metabolic vulnerability in NOTCH-driven T cell acute lymphoblastic leukaemia ( Dr Etienne De Braekeleer - Wellcome Sanger Institute, Cambridge, UK )
24 May 2019
MLL-rearranged acute lymphoblastic leukaemia
Dr Pablo Menéndez - Josep Carreras Leukemia Research Institute, Barcelona, Spain
MLL-rearranged acute lymphoblastic leukaemia ( Dr Pablo Menéndez - Josep Carreras Leukemia Research Institute, Barcelona, Spain )
24 May 2019
Updates on bispecific T cell engagers (BiTEs) for the treatment of acute...
Prof Max Topp - University of Würzburg, Würzburg, Germany
Updates on bispecific T cell engagers (BiTEs) for the treatment of acute lymphoblastic leukaemia ( Prof Max Topp - University of Würzburg, Würzburg, Germany )
24 May 2019
Using CAR T cells for the treatment of acute lymphoblastic leukaemia
Prof Claudia Rossig - Universität Münster, Münster, Germany
Using CAR T cells for the treatment of acute lymphoblastic leukaemia ( Prof Claudia Rossig - Universität Münster, Münster, Germany )
24 May 2019

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation